CHRW vs EFX
C.H. Robinson vs Equifax — AI-powered side-by-side comparison
CHRW
C.H. Robinson
60
Buy
VS
| Metric | CHRW | EFX |
|---|
| AI Score |
60
|
55
|
| Price |
$151.68
|
$190.57
|
| P/E Ratio |
27.05×
|
33.49×
|
| ROE |
31.8%
|
14.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
10.1%
|
44.4%
|
| Debt / Equity |
1.21×
|
1.25×
|
| Dividend Yield |
1.7%
|
1.1%
|
| RSI (14) |
34.3
|
63.8
|
| Beta |
0.946
|
1.296
|
| Expected Upside |
+32.3%
|
+2.2%
|
AI Committee View
Current Innellis committee reasoning for CHRW versus EFX.
CHRW leads by 5 points.
CHRW scores 60/100 (Buy) versus EFX at 55/100 (Watch).
CHRW Committee View
67% agreement
6 analysts
The primary driver is news sentiment is positive (+0.44 across 9 articles, 14d). The main limiting factor is p/e of 27.6 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 36.0% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.0% pays you to wait — Value
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- P/E of 27.6 is moderate-to-rich — Value
- Price-to-book of 10.3x prices in significant intangible value — Value
- Revenue declining -0.1% YoY -- this is not a growth story right now — Growth
EFX Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Value Analyst remains cautious — p/e of 30.7 is moderate-to-rich. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 30.7 is moderate-to-rich — Value
- Price-to-book of 5.8x prices in significant intangible value — Value
- Current ratio of 0.60 is tight -- limited short-term liquidity cushion — Risk